NHTSA public meeting to address drug-impaired driving

Agency brings together key stakeholders to problem solve

Posted March 2, 2018

The National Highway Traffic Safety Administration (NHTSA) is hosting a public meeting on March 15, 2018, to promote dialogue on the growing problem of drug-impaired driving on U.S. roads.

Driving under the influence of drugs is on the rise and responsible for thousands of driving-related fatalities, according to the NHTSA. The Drug-Impaired Driving Call to Action meeting launches the agency’s initiative to develop action plans to combat drugged driving.

The public meeting will bring together key stakeholders to brainstorm. Participants will include safety partners; state and local officials; data and policy experts; law enforcement and criminal justice professionals; toxicologists; drug recognition experts; and others.

Want to attend?

The meeting will be held on March 15th at the Atrium of the West Building of the U.S. Department of Transportation, located at 1200 New Jersey Avenue SE, Washington, DC 20590 from 9:00 a.m. to 4:00 p.m., EST. To reserve a spot, you must RSVP by March 13, 2018.

NHTSA cautions that attendance is limited because of space limitations of the facility. The meeting will also be available for live public viewing on the NHTSA website.


Alcohol & Drugs DOT Compliance ManualJ. J. Keller's Alcohol & Drugs DOT Compliance Manual can help you understand and comply with DOT's Alcohol & Drug Testing requirements, including 49 CFR Parts 382 and 40.

 

J. J. Keller's FREE Transportation SafetyClicks™ email newsletter brings quick-read safety and compliance news right to your email box.

Sign up to receive Transportation SafetyClicks™.